Fertility and Sterility/LinkedIn
Oct 12, 2025, 07:57
Relugolix Combo Therapy in Fibroids and Adenomyosis – Fertility and Sterility
Fertility and Sterility shared a post on LinkedIn about a paper by William H. Catherino et al. published in Fertility and Sterility:
“Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: Subgroup analysis of LIBERTY 1 and LIBERTY 2
Title: Efficacy and safety of relugolix combination therapy in women with uterine fibroids and adenomyosis: subgroup analysis of LIBERTY 1 and LIBERTY 2
Authors: William H. Catherino, Ayman Al-Hendy, Souhil Zaim, Nadia Bouzegaou, Roberta Venturella, Elizabeth A. Stewart, Rui Wu, Silvia Vannuccini, Julie S. Perry, Viatcheslav G. Rakov, Malcolm G. Munro
-
May 6, 2026, 01:35Alison Wright: BSGE 2026 Highlights Leadership Change and Future Vision
-
May 6, 2026, 01:30Short Menstrual Cycles May Signal Early Ovarian Ageing – Fertility Plus
-
May 6, 2026, 01:27Asma Khalil: Maternal Mental Health Remains a Leading Risk
-
May 5, 2026, 16:55Pregnancy Outcomes in a Recurrent Miscarriage Population After Uterine Surgeries – Fertility and Sterility
-
May 5, 2026, 16:43MAGENTA Oocyte Scores, Morphokinetics and Live Birth – Future Fertility
-
May 5, 2026, 16:34Join Us on 16 September to Explore Challenges in Managing a Successful Fertility Service – BFS
-
May 5, 2026, 16:17Mature Oocyte Retrieval Without an Exogenous Trigger During Stimulation – Fertility and Sterility
-
May 5, 2026, 16:08We Are Delighted to Announce that Fertility 2027 Registration Opens soon – Fertility Conferences
-
May 5, 2026, 15:59Lillian’s Story Highlights Urgency of Recognising Postpartum Preeclampsia – Preeclampsia Foundation